Net gamma exposure for Repligen Corp (RGEN) options was negative at the Nov 4, 2026 close, about $292.92K per 1% move in the stock. It has been positive on 1 of the last 20 trading days. With negative gamma, dealer hedging tends to follow price moves, which can make swings larger.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for RGEN, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for RGEN, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for RGEN, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
RGEN Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is RGEN gamma exposure positive or negative?
Repligen net gamma exposure was negative on Nov 4, 2026, at -$292.92K. It has been positive on 1 of the last 20 trading days.
How has RGEN gamma exposure changed recently?
Repligen net gamma exposure went from -$601.7K on Oct 7, 2026 to -$292.92K on Nov 4, 2026. See the RGEN gamma exposure history for a longer view.
What is Repligen Corp?
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies.